Physician

Christopher Richard Mitromaras, MD

According to 2025 Medicare claims, Christopher Mitromaras, MD (NPI: 1801104971) practices vascular surgery in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Cabarrus, NC. This provider's primary affiliated billing organization is CAROLINAS PHYSICIANS NETWORK INC (NPI: 1710290564; TIN: 561667838) and primary practice location at 28025-2927. Mitromaras is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675) and UT Health San Antonio Regional Physician Network (ACO ID: A4678), participating under the MSSP model.

Mitromaras' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 577 traditional Medicare patients, billed 1,622 HCPCS/CPT codes, and received $207,936 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 286 prescription claims across 93 beneficiaries totaling $36,837 in drug costs, led by Xarelto (Rivaroxaban). 2023 DME data shows 32 claims. Open Payments data shows 25 records totaling $2,948. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $6,823 to $207,936. Similarly, Part D prescription costs have risen steadily, from $953 to $36,837. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	17	64	$6,823
2016	76	239	$36,463
2017	N/R	N/R	N/R
2018	141	317	$44,085
2019	491	1,642	$203,813
2020	394	1,457	$160,460
2021	254	1,214	$180,965
2022	361	1,224	$190,687
2023	456	1,285	$171,913
2024	577	1,622	$207,936

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	23	40	$953
2017	22	60	$3,842
2018	21	38	$562
2019	69	148	$12,894
2020	54	132	$17,098
2021	53	106	$8,664
2022	61	140	$13,361
2023	73	199	$21,501
2024	93	286	$36,837

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	32	$516
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	147	157	$125
93978	Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts	108	116	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	76	92	$94
93922	Ultrasound study of arm and leg arteries	160	192	$48
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	95	112	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	22	1,200	$21,993
Eliquis	Apixaban	16	660	$12,899
Clopidogrel	Clopidogrel Bisulfate	93	6,651	$789
Gabapentin	Gabapentin	15	1,080	$294
Atorvastatin Calcium	Atorvastatin Calcium	43	3,570	$250

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$2,948	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Richard Mitromaras, MD?

Tedicare shows public-source Medicare data for Christopher Richard Mitromaras, MD (NPI 1801104971), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Richard Mitromaras, MD have ACO affiliation data?

Christopher Richard Mitromaras, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675) and UT Health San Antonio Regional Physician Network (MSSP, ACO ID A4678).

What billing organization is linked to Christopher Richard Mitromaras, MD?

Christopher Richard Mitromaras, MD is linked to CAROLINAS PHYSICIANS NETWORK INC (billing NPI 1710290564) in the available physician profile data.

Does Christopher Richard Mitromaras, MD have Open Payments data?

Christopher Richard Mitromaras, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.